Cargando…
A polymer-based drug delivery system for the antineoplastic agent bis(maltolato)oxovanadium in mice.
Using vanadyl sulphate, sodium orthovanadate or bis(maltolato)oxovanadium (BMOV), Cruz TF, Morgan A, Min W (1995, Mol Cell Biochem 153: 161-166) have recently demonstrated the antineoplastic effects of vanadium in mice. In this study, the antineoplastic effects of BMOV against human tumour cell line...
Autores principales: | Jackson, J. K., Min, W., Cruz, T. F., Cindric, S., Arsenault, L., Von Hoff, D. D., Degan, D., Hunter, W. L., Burt, H. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222752/ https://www.ncbi.nlm.nih.gov/pubmed/9083337 |
Ejemplares similares
-
Bis(maltolato)oxovanadium(IV) Induces Angiogenesis via Phosphorylation of VEGFR2
por: Parma, Laura, et al.
Publicado: (2020) -
Bis maltolato oxovanadium (BMOV) and ischemia/reperfusion-induced acute kidney injury in rats
por: Almac, Emre, et al.
Publicado: (2014) -
Elucidating the Therapeutic Potential of Bis(Maltolato)OxoVanadium(IV): The Protective Role of Copper in Cellular Metabolism
por: Rivas-García, Lorenzo, et al.
Publicado: (2023) -
Changes in Iron Metabolism and Oxidative Status in STZ-Induced Diabetic Rats Treated with Bis(maltolato) Oxovanadium (IV) as an Antidiabetic Agent
por: Sánchez-González, Cristina, et al.
Publicado: (2014) -
Antidiabetic Bis-Maltolato-OxoVanadium(IV): Conversion of inactive trans- to bioactive cis-BMOV for possible binding to target PTP-1B
por: Scior, Thomas, et al.
Publicado: (2009)